{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:34:58Z","timestamp":1791920098751,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T00:00:00Z","timestamp":1623974400000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["cghjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.cgh.2019.10.010","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T12:00:07Z","timestamp":1571054407000},"page":"1851-1857","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0784-0710","authenticated-orcid":false,"given":"Edouard","family":"Bardou-Jacquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Morandeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant A.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise E.","family":"Ramm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeff","family":"Morcet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bouzille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D.","family":"Clouston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Lain\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Turlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrie W.","family":"Powell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves M.","family":"Deugnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cgh.2019.10.010_bib1","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1053\/gast.2002.33023","article-title":"Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C","volume":"122","author":"Poynard","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.10.010_bib2","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.cgh.2019.10.010_bib3","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1002\/hep.21260","article-title":"Reversibility of hepatic fibrosis in treated genetic hemochromatosis: a study of 36 cases","volume":"44","author":"Falize","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.10.010_bib4","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1001\/archinte.166.3.294","article-title":"Screening for hemochromatosis in asymptomatic subjects with or without a family history","volume":"166","author":"Powell","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cgh.2019.10.010_bib5","doi-asserted-by":"crossref","first-page":"981","DOI":"10.7326\/0003-4819-127-11-199712010-00006","article-title":"Reversibility of hepatic fibrosis in autoimmune hepatitis","volume":"127","author":"Dufour","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2019.10.010_bib6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-126-9-199705010-00002","article-title":"Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment","volume":"126","author":"Kaplan","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.cgh.2019.10.010_bib7","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1053\/j.gastro.2015.04.014","article-title":"Bariatric surgery reduces features of nonalcoholic steatohepatitis in morbidly obese patients","volume":"149","author":"Lassailly","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.10.010_bib8","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.5858\/2000-124-1599-ROHC","article-title":"Regression of human cirrhosis: morphologic features and the genesis of incomplete septal cirrhosis","volume":"124","author":"Wanless","year":"2000","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cgh.2019.10.010_bib9","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.jhep.2011.09.024","article-title":"Clinical evidence for the regression of liver fibrosis","volume":"56","author":"Ellis","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.10.010_bib10","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1053\/jhep.2002.35343","article-title":"Noninvasive prediction of cirrhosis in C282Y-linked hemochromatosis","volume":"36","author":"Beaton","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.10.010_bib11","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa073286","article-title":"Iron-overload-related disease in HFE hereditary hemochromatosis","volume":"358","author":"Allen","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cgh.2019.10.010_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.jhep.2014.10.025","article-title":"Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis","volume":"62","author":"Bardou-Jacquet","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.10.010_bib13","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s002770100371","article-title":"Clinically overt hereditary hemochromatosis in Denmark 1948-1985: epidemiology, factors of significance for long-term survival, and causes of death in 179 patients","volume":"80","author":"Milman","year":"2001","journal-title":"Ann Hematol"},{"key":"10.1016\/j.cgh.2019.10.010_bib14","first-page":"611","article-title":"Long term results of venesection therapy in idiopathic haemochromatosis","volume":"45","author":"Bomford","year":"1976","journal-title":"Q\u00a0J Med"},{"key":"10.1016\/j.cgh.2019.10.010_bib15","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1053\/gast.1996.v110.pm8613000","article-title":"Long-term survival in patients with hereditary hemochromatosis","volume":"110","author":"Niederau","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.10.010_bib16","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/j.jhep.2004.03.007","article-title":"Cirrhosis reversal: a duel between dogma and myth","volume":"40","author":"Desmet","year":"2004","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.10.010_bib17","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/hep.1840220417","article-title":"Portal hypertension and iron depletion in patients with genetic hemochromatosis","volume":"22","author":"Fracanzani","year":"1995","journal-title":"Hepatology (Baltimore, Md)"},{"key":"10.1016\/j.cgh.2019.10.010_bib18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2893.2005.00582.x","article-title":"Impact of interferon-alpha therapy on liver fibrosis progression in patients with HBeAg-negative chronic hepatitis B","volume":"12","author":"Papatheodoridis","year":"2005","journal-title":"J\u00a0Viral Hepat"},{"key":"10.1016\/j.cgh.2019.10.010_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.20535","article-title":"Sources of variability in histological scoring of chronic viral hepatitis","volume":"41","author":"Rousselet","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.10.010_bib20","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.cgh.2019.10.010_bib21","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.humpath.2006.07.007","article-title":"Direct and indirect evidence for the reversibility of cirrhosis","volume":"37","author":"Serpaggi","year":"2006","journal-title":"Hum Pathol"},{"key":"10.1016\/j.cgh.2019.10.010_bib22","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jhep.2012.04.029","article-title":"The Laennec staging system for histological sub-classification of cirrhosis is useful for stratification of prognosis in patients with liver cirrhosis","volume":"57","author":"Kim","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.cgh.2019.10.010_bib23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1053\/j.gastro.2008.10.052","article-title":"Elevated serum alanine aminotransferase and gamma-glutamyltransferase and mortality in the United States population","volume":"136","author":"Ruhl","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.10.010_bib24","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MCG.0000000000000400","article-title":"Insulin resistance is associated with significant liver fibrosis in chronic hepatitis C patients: a systemic review and meta-analysis","volume":"50","author":"Patel","year":"2016","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1016\/j.cgh.2019.10.010_bib25","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1002\/hep.25720","article-title":"Clinical cofactors and hepatic fibrosis in hereditary hemochromatosis: the role of diabetes mellitus","volume":"56","author":"Wood","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.cgh.2019.10.010_bib26","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.cgh.2007.02.039","article-title":"Incidence and predictors of hepatocellular carcinoma in patients with cirrhosis","volume":"5","author":"Ioannou","year":"2007","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.cgh.2019.10.010_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1053\/j.gastro.2016.09.009","article-title":"Eradication of hepatitis C virus infection in patients with cirrhosis reduces risk of liver and non-liver complications","volume":"152","author":"Nahon","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.cgh.2019.10.010_bib28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.jhep.2009.12.028","article-title":"Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: incidence and survival in hepatitis C patients with advanced fibrosis","volume":"52","author":"Cardoso","year":"2010","journal-title":"J\u00a0Hepatol"}],"container-title":["Clinical Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519311097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1542356519311097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T05:31:39Z","timestamp":1761543099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1542356519311097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S1542356519311097"],"URL":"https:\/\/doi.org\/10.1016\/j.cgh.2019.10.010","relation":{},"ISSN":["1542-3565"],"issn-type":[{"value":"1542-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Regression of Fibrosis Stage With Treatment Reduces Long-Term Risk of Liver Cancer in Patients With Hemochromatosis Caused by Mutation in HFE","name":"articletitle","label":"Article Title"},{"value":"Clinical Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cgh.2019.10.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 by the AGA Institute","name":"copyright","label":"Copyright"}]}}